Bioo Therapeutics, Texas Tech Research Collaborate on siRNA Delivery to T Cells

Bioo Therapeutics, a division of Bioo Scientific, said this month that it has signed a collaborative research agreement with Texas Tech University researcher Premlata Shankar to develop methods to deliver siRNAs into T cells.

Written by: Jessica Behnham

Bioo Therapeutics, a division of Bioo Scientific, said this month that it has signed a collaborative research agreement with Texas Tech University researcher Premlata Shankar to develop methods to deliver siRNAs into T cells.

Under the deal, Shankar will use Bioo's Targeted Transport Technology, which involves joining a carrier agent to a monoclonal antibody to produce a conjugate that is then loaded with an RNAi molecule such as an siRNA or miRNA mimic, to deliver anti-HIV siRNAs into T cells.

Read the rest of the story at GenomeWeb Daily News